Caricamento...
Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors
Background: Most patients with advanced gastrointestinal stromal tumors (GIST) develop drug resistance to tyrosine kinase inhibitors (TKIs) within two years of starting therapy, whereas most chronic myeloid leukemia (CML) patients in chronic phase still exhibit disease control after a decade on ther...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000Research
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3892920/ https://ncbi.nlm.nih.gov/pubmed/24555070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.2-152.v1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|